Literature DB >> 25845579

CLINICAL CONSEQUENCES OF THE REVISED DSM-5 DEFINITION OF AGORAPHOBIA IN TREATMENT-SEEKING ANXIOUS YOUTH.

Danielle Cornacchio1, Tommy Chou1, Hayley Sacks2, Donna Pincus3, Jonathan Comer1.   

Abstract

BACKGROUND: In DSM-5, the agoraphobia core symptom criterion has been revised to require fear about multiple situations from across at least two distinct domains in which escape might be difficult or panic-like symptoms might develop. The present study examined patterns and correlates of the recent change in a sample of anxious youth with symptom presentations consistent with the DSM-IV agoraphobia definition and/or specific phobia (SP) to consider how the recent diagnostic change impacts the prevalence and composition of agoraphobia in children and adolescents.
METHOD: Analyses (N = 151) evaluated impairment and correlates of agoraphobic youth who no longer meet the DSM-5 agoraphobia criteria relative to agoraphobic youth who do meet the new DSM-5 criteria. Secondary analyses compared agoraphobic youth not meeting DSM-5 criteria to SP youth.
RESULTS: One-quarter of youth with symptom presentations consistent with the DSM-IV agoraphobia definition no longer met criteria for DSM-5 agoraphobia, but showed comparable severity and impairment across most domains to youth who do meet criteria for DSM-5 agoraphobia. Further, these youth showed higher levels of anxiety sensitivity and internalizing psychopathology relative to youth with SP.
CONCLUSIONS: A substantial proportion of impaired youth with considerable agoraphobic symptom presentations have been left without a specified anxiety diagnosis by the DSM-5, which may affect their ability to receive and/or get coverage for services and their representation in treatment evaluations. Future DSM iterations may do well to include a "circumscribed" agoraphobia specifier that would characterize presentations of fear or anxiety about multiple situations, but that do not span across at least two distinct situational domains.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  agoraphobia; anxiety; assessment; child/adolescent; diagnosis; phobias

Mesh:

Year:  2015        PMID: 25845579      PMCID: PMC5340313          DOI: 10.1002/da.22361

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  26 in total

1.  Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.

Authors:  Ronald C Kessler; Shelli Avenevoli; E Jane Costello; Katholiki Georgiades; Jennifer Greif Green; Michael J Gruber; Jian-ping He; Doreen Koretz; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

Review 2.  Evidence-based assessment of anxiety and its disorders in children and adolescents.

Authors:  Wendy K Silverman; Thomas H Ollendick
Journal:  J Clin Child Adolesc Psychol       Date:  2005-09

3.  Depression in British and American children and its relation to anxiety and fear.

Authors:  T H Ollendick; W Yule
Journal:  J Consult Clin Psychol       Date:  1990-02

4.  The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Sharon Smith; Rise B Goldstein; W June Ruan; Bridget F Grant
Journal:  Psychol Med       Date:  2007-03-05       Impact factor: 7.723

5.  Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  Jeffrey J Wood; John C Piacentini; R Lindsey Bergman; James McCracken; Velma Barrios
Journal:  J Clin Child Adolesc Psychol       Date:  2002-09

Review 6.  Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V.

Authors:  Richard T LeBeau; Daniel Glenn; Betty Liao; Hans-Ulrich Wittchen; Katja Beesdo-Baum; Thomas Ollendick; Michelle G Craske
Journal:  Depress Anxiety       Date:  2010-02       Impact factor: 6.505

7.  Children's depression inventory: sex and grade norms for normal children.

Authors:  A J Finch; C F Saylor; G L Edwards
Journal:  J Consult Clin Psychol       Date:  1985-06

8.  Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.

Authors:  Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2012-08-01       Impact factor: 4.035

9.  The relationship of agoraphobia and panic in a community sample of adolescents and young adults.

Authors:  H U Wittchen; V Reed; R C Kessler
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  A symptom-level examination of parent-child agreement in the diagnosis of anxious youths.

Authors:  Jonathan S Comer; Philip C Kendall
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829

View more
  3 in total

1.  Disqualified qualifiers: evaluating the utility of the revised DSM-5 definition of potentially traumatic events among area youth following the Boston marathon bombing.

Authors:  Tommy Chou; Aubrey L Carpenter; Caroline E Kerns; R Meredith Elkins; Jennifer Greif Green; Jonathan S Comer
Journal:  Depress Anxiety       Date:  2016-07-19       Impact factor: 6.505

2.  The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents.

Authors:  Peter Muris; Ellin Simon; Hester Lijphart; Arjan Bos; William Hale; Kelly Schmeitz
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

3.  A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys.

Authors:  Annelieke M Roest; Ymkje Anna de Vries; Carmen C W Lim; Hans-Ulrich Wittchen; Dan J Stein; Tomasz Adamowski; Ali Al-Hamzawi; Evelyn J Bromet; Maria Carmen Viana; Giovanni de Girolamo; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; José Miguel Caldas-de-Almeida; Norito Kawakami; Jean Pierre Lépine; Daphna Levinson; Maria E Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José A Posada-Villa; Tim Slade; Yolanda Torres; Ronald C Kessler; Kate M Scott; Peter de Jonge
Journal:  Depress Anxiety       Date:  2019-02-06       Impact factor: 6.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.